T1	Entity 141 160	the stem cell field
T2	Cluster1 235 241	hiPSCs
T3	Entity 243 250	n = 114
T4	Cluster2 256 261	hESCs
T5	Entity 263 270	n = 155
T6	Cluster1 345 351	hiPSCs
T7	Cluster2 357 362	hESCs
T8	Cluster5 299 301	82
T9	Entity 288 295	a panel
T10	Entity 439 455	hypermethylation
T11	Cluster4 467 473	DNMT3B
T12	Cluster4 484 490	DNMT3B
T13	Cluster9 515 540	aberrant hypermethylation
T14	Entity 545 554	silencing
T15	Cluster4 613 619	DNMT3B
T16	Entity 672 685	reprogramming
T17	Entity 180 188	analyzed
T18	Entity 277 287	identified
T19	Cluster12 368 381	high accuracy
T20	Cluster5 767 769	82
T21	Entity 809 819	biomarkers
T22	Cluster5 874 884	Eighty-two
T23	Cluster12 941 954	high accuracy
T24	Entity 957 963	Twelve
T25	Cluster4 1029 1035	DNMT3B
T26	Cluster4 1038 1044	DNMT3B
T27	Cluster9 1085 1110	aberrant hypermethylation
T28	Cluster1 1114 1120	hiPSCs
T29	Cluster5 1154 1156	82
T30	Cluster1 1209 1215	hiPSCs
T31	Cluster2 1221 1226	hESCs
T32	Cluster12 1232 1245	high accuracy
T33	Cluster4 1367 1373	DNMT3B
T34	Entity 1329 1348	partially abrogated
T35	Entity 1255 1268	the signature
T36	Entity 1143 1150	a panel
T37	Entity 58 72	epigenetically
T38	Cluster1 8 53	human induced pluripotent stem cells (hiPSCs)
T39	Cluster2 86 120	human embryonic stem cells (hESCs)
T40	Entity 189 213	DNA methylation patterns
T41	Cluster3 302 323	CpG methylation sites
T42	Entity 396 412	12 out of the 82
T43	Cluster3 413 422	CpG sites
T44	Entity 558 585	the signature gene, TCERG1L
T45	Cluster11 635 664	a wave of de novo methylation
T46	Entity 721 759	the unique hiPSC methylation signature
T47	Entity 770 791	CpG methylation sites
T48	Cluster3 885 906	DNA methylation sites
T49	Entity 964 1009	aberrantly hypermethylated signature CG sites
T50	Cluster3 1157 1178	CpG methylation sites
T51	Cluster10 1281 1317	aberrantly hypermethylated CpG sites
T52	Entity 1388 1408	DNMT3B-mutant hiPSCs
T53	Entity 1424 1466	other aberrant hypermethylation signatures
T54	Entity 333 344	distinguish
T55	Entity 823 834	distinguish
T56	Cluster1 843 849	hiPSCs
T57	Cluster2 854 859	hESCs
T58	Entity 907 918	distinguish
T59	Cluster1 919 925	hiPSCs
T60	Cluster2 930 935	hESCs
T61	Entity 1197 1208	distinguish
T62	Cluster7 1143 1245	a panel of 82 CpG methylation sites that can robustly distinguish hiPSCs from hESCs with high accuracy
T63	Cluster7 288 381	a panel of 82 CpG methylation sites that can distinguish hiPSCs from hESCs with high accuracy
T64	Cluster8 177 179	we
T65	Cluster8 383 385	We
T66	Cluster8 596 598	we
T67	Cluster3 1179 1183	that
T68	Cluster10 1319 1324	which
T69	Cluster11 700 705	which
T70	Cluster3 324 328	that
T71	Cluster7 761 791	These 82 CpG methylation sites
